Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 9.6 -4.38% -0.44
VRCA closed down 4.38 percent on Monday, December 17, 2018, on 79 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical VRCA trend table...

Date Alert Name Type % Chg
Dec 17 New 52 Week Closing Low Bearish 0.00%
Dec 17 New 52 Week Low Weakness 0.00%
Dec 17 Multiple of Ten Bearish Other 0.00%
Dec 17 Wide Bands Range Expansion 0.00%
Dec 17 Down 3 Days in a Row Weakness 0.00%
Dec 17 Oversold Stochastic Weakness 0.00%
Dec 14 Spinning Top Other -4.38%
Dec 14 Multiple of Ten Bullish Other -4.38%
Dec 14 Wide Bands Range Expansion -4.38%
Dec 14 Oversold Stochastic Weakness -4.38%

Older signals for VRCA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: 2018-11-06
Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
Is VRCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Dec 8 Stocks To Watch: Tencent Music, Starbucks And Under Armour In Focus
Dec 7 The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Dec 6 The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering
Nov 28 The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings
Nov 16 Market Trends Toward New Normal in PlayAGS, BEST, Inc. Sponsored ADR, Verrica Pharmaceuticals, Telenav, bluebird bio, and CompX International — Emerging Consolidated Expectations, Analyst Ratings
Nov 13 70 Biggest Movers From Yesterday
Nov 12 Healthcare and Tech tops midday movers
Nov 12 ReShape Lifesciences leads healthcare gainers; Infinity Pharmaceuticals and Achaogen among losers
Nov 7 Verrica Pharmaceuticals misses by $0.03
Nov 7 Verrica Pharmaceuticals Reports Third Quarter 2018 Financial Results
See more VRCA news...
Indicators
Indicator Value
52 Week High 23.29
52 Week Low 9.6
Average Volume 38,187
200-Day Moving Average 0.0
50-Day Moving Average 12.5876
20-Day Moving Average 11.263
10-Day Moving Average 10.356
Average True Range 0.8556
ADX 16.21
+DI 13.6915
-DI 22.2848
Chandelier Exit (Long, 3 ATRs ) 12.8332
Chandelier Exit (Short, 3 ATRs ) 12.1668
Upper Bollinger Band 13.4515
Lower Bollinger Band 9.0745
Percent B (%b) 0.12
BandWidth 38.86176
MACD Line -0.8906
MACD Signal Line -0.8011
MACD Histogram -0.0895
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.65
Resistance 3 (R3) 10.77 10.53 10.48
Resistance 2 (R2) 10.53 10.27 10.48 10.42
Resistance 1 (R1) 10.07 10.10 9.95 9.95 10.36
Pivot Point 9.83 9.83 9.78 9.78 9.83
Support 1 (S1) 9.37 9.57 9.25 9.25 8.84
Support 2 (S2) 9.13 9.40 9.08 8.78
Support 3 (S3) 8.67 9.13 8.73
Support 4 (S4) 8.55